Patents Assigned to Biopolymer Engineering Pharmaceutical, Inc.
  • Assay for binding between carbohydrate and glycolipid
    Patent number: 6630310
    Abstract: A preparation containing a receptor for underivatized, aqueous soluble &bgr;(1-3)-glucan is disclosed, along with characterization of the receptor for underivatized, aqueous soluble &bgr;(1-3)-glucan. Also described are assays for identifying agents which alter the effect of underivatized, aqueous soluble &bgr;(1-3)-glucan on activation of signal transduction pathways and agents identified thereby, as well as assays for assessing the specificity of carbohydrate:glycolipid interactions.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: October 7, 2003
    Assignee: Biopolymer Engineering Pharmaceutical, Inc.
    Inventors: Eric Wakshull, William M. Mackin, Janet Zimmerman
  • Very high molecular weight &bgr;-glucans
    Patent number: 6369216
    Abstract: The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble &bgr;-glucan composition comprising &bgr;-glucan molecules having an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering (VHMW-glucan).
    Type: Grant
    Filed: June 3, 1999
    Date of Patent: April 9, 2002
    Assignee: Biopolymer Engineering Pharmaceutical, Inc.
    Inventors: Myra L. Patchen, Spiros Jamas, D. Davidson Easson, Jr., Gary R. Ostroff